成功应用病灶内注射英夫利昔单抗治疗经典型坏疽性脓皮病：一例报告。
Successful treatment of classic pyoderma gangrenosum with intralesional infliximab injection: A case report.
机构信息
Molecular Dermatology Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.
Department of Dermatology, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran.
出版信息
Australas J Dermatol. 2023 Aug;64(3):e252-e255. doi: 10.1111/ajd.14072. Epub 2023 May 16.
Pyoderma gangrenosum (PG) is a rare dermatological disease characterized by the rapid development of painful skin ulcers. While systemic infliximab is considered a standard treatment for patients with PG, herein, we report our success with the use of intralesional infliximab in a 40-year-old woman with systemic lupus erythematosus (SLE) and PG.
坏疽性脓皮病（PG）是一种罕见的皮肤科疾病，其特征为迅速发展的疼痛性皮肤溃疡。虽然全身性英夫利昔单抗被认为是 PG 患者的标准治疗方法，但在此，我们报告了一例 40 岁系统性红斑狼疮（SLE）合并 PG 女性患者使用病灶内注射英夫利昔单抗治疗成功的病例。
Zotero 插件